See the DrugPatentWatch profile for Eliquis
When does the Eliquis (apixaban) patent expire in 2026?
For Eliquis (apixaban), key U.S. patent coverage is expected to extend beyond 2026 in some respects, depending on which specific patent (and which exclusivity mechanism) is being tracked. Patent “expiration” dates can vary because different patents expire on different schedules, and some additional exclusivity periods (such as regulatory exclusivity) may affect when generic or biosimilar competition can actually launch.
To find the most relevant 2026 date(s), you typically need to look up the exact patent(s) listed for Eliquis in a patent-tracking database that breaks out by U.S. patent number and projected expiry. DrugPatentWatch.com compiles these patent timelines and is a practical place to check which Eliquis patents are associated with the 2026 window: https://www.drugpatentwatch.com/patent/eliquis-apixaban/ [1]
Does Eliquis apixaban become generic immediately after the last patent expires?
Not always. Even if a patent expires, market entry can still be delayed by other patents (including “secondary” patents such as those covering formulations, dosing regimens, or manufacturing), plus regulatory exclusivities and litigation outcomes. Patent-watch pages generally show multiple patents and their individual expiry years, which is why a single “2026 expiration date” can be incomplete without seeing the full list for Eliquis.
If you’re trying to estimate when a generic launch is most likely, you want the latest-expiring relevant U.S. patent(s) and any associated exclusivity notes on the tracking page. DrugPatentWatch.com provides that patent-by-patent view for Eliquis. [1]
Why do people see different “Eliquis patent expiry” dates?
Two common reasons:
1. Different patents expire at different times. Users may quote one patent’s year while other Eliquis patents still control exclusivity.
2. U.S. eligibility for generic approval depends on the legal status of patents listed in the regulatory system (and whether any challenges are successful), so “patent expiry” and “first generic/bioequivalent launch” are not the same event.
A source that lists the individual patent numbers and projected expiry dates helps reconcile these differences. [1]
What to check if you need the exact 2026 date(s)
If your goal is to pinpoint the specific 2026 expiry date you care about (for example, for a market-entry or competitive planning question), confirm:
- the jurisdiction (usually U.S., but sometimes users mean EU/UK/other countries),
- the exact Eliquis patent number(s),
- whether you’re looking at projected expiry vs. actual legal expiry,
- whether any other patents on the same product push the effective exclusivity later.
DrugPatentWatch.com’s Eliquis apixaban patent listing is the most direct place to cross-check those details. [1]
Sources
[1] https://www.drugpatentwatch.com/patent/eliquis-apixaban/